Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-012232
Filing Date
2015-08-17
Accepted
2015-08-17 17:27:06
Documents
1
Period of Report
2015-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7949
  Complete submission text file 0001179110-15-012232.txt   9510
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address
von Emster Kurt (Reporting) CIK: 0001588856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 151059665